Myomar Aims For Regulatory Approval This Summer
Myomar Molecular hopes to use some of the $1.1 million funding round it just closed to win Health Canada approval for its muscle health test by the end of June, as the company prepares for another raise later this year, CEO Rafaela Andrade said in an interview Friday.
The deal, which included a mix of equity and non-dilutive funding, was led by a Nova Scotia angel investor, with the Atlantic